# Oral Isotretinoin for Photoaging: Results of a Randomized Controlled Phase II Trial

> **NCT00701740** · PHASE2 · COMPLETED · sponsor: **Federal University of São Paulo** · enrollment: 32 (actual)

## Conditions studied

- Photoaging
- Epidermal p53 Expression

## Interventions

- **DRUG:** oral isotretinoin and Mexoryl SX / XL
- **DRUG:** Mexoryl XL / SX

## Key facts

- **NCT ID:** NCT00701740
- **Lead sponsor:** Federal University of São Paulo
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-07
- **Primary completion:** 2008-01
- **Final completion:** 2008-06
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2018-08-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00701740

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00701740, "Oral Isotretinoin for Photoaging: Results of a Randomized Controlled Phase II Trial". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00701740. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*